Literature DB >> 21862580

Akt fine-tunes NF-κB-dependent gene expression during T cell activation.

Jing Cheng1, Binh Phong, David C Wilson, Raphael Hirsch, Lawrence P Kane.   

Abstract

Activation of the NF-κB signaling pathway is critical for leukocyte activation and development. Although previous studies suggested a role for the Akt kinase in coupling the T cell antigen receptor and CD28 to NF-κB activation in T cells, the nature of the role of Akt in this pathway is still unclear. Using a targeted gene profiling approach, we found that a subset of NF-κB-dependent genes required Akt for optimal up-regulation during T cell activation. The selective effects of Akt were manifest at the level of mRNA transcription and p65/RelA binding to upstream promoters and appear to be due to altered formation of the Carma1-Bcl10 complex. The proinflammatory cytokine TNF-α was found to be particularly sensitive to Akt inhibition or knockdown, including in primary human blood T cells and a murine model of rheumatoid arthritis. Our findings are consistent with a hierarchy in the expression of NF-κB-dependent genes, controlled by the strength and/or duration of NF-κB signaling. More broadly, our results suggest that defining the more graded effects of signaling, such as those demonstrated here for Akt and the NF-κB pathway, is important to understanding how cells can fine-tune signaling responses for optimal sensitivity and specificity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862580      PMCID: PMC3195567          DOI: 10.1074/jbc.M111.259549

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.

Authors:  S Cenci; M N Weitzmann; C Roggia; N Namba; D Novack; J Woodring; R Pacifici
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

2.  Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines.

Authors:  L P Kane; P G Andres; K C Howland; A K Abbas; A Weiss
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

3.  Akti-1/2, an allosteric inhibitor of Akt 1 and 2, efficiently inhibits CaMKIα activity and aryl hydrocarbon receptor pathway.

Authors:  David Gilot; Fanny Giudicelli; Dominique Lagadic-Gossmann; Olivier Fardel
Journal:  Chem Biol Interact       Date:  2010-09-09       Impact factor: 5.192

Review 4.  Selective transcription in response to an inflammatory stimulus.

Authors:  Stephen T Smale
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

5.  Pulsatile stimulation determines timing and specificity of NF-kappaB-dependent transcription.

Authors:  Louise Ashall; Caroline A Horton; David E Nelson; Pawel Paszek; Claire V Harper; Kate Sillitoe; Sheila Ryan; David G Spiller; John F Unitt; David S Broomhead; Douglas B Kell; David A Rand; Violaine Sée; Michael R H White
Journal:  Science       Date:  2009-04-10       Impact factor: 47.728

6.  A noisy paracrine signal determines the cellular NF-kappaB response to lipopolysaccharide.

Authors:  Timothy K Lee; Elissa M Denny; Jayodita C Sanghvi; Jahlionais E Gaston; Nathaniel D Maynard; Jacob J Hughey; Markus W Covert
Journal:  Sci Signal       Date:  2009-10-20       Impact factor: 8.192

7.  Follistatin-like protein 1 promotes arthritis by up-regulating IFN-gamma.

Authors:  Suzanne D Clutter; David C Wilson; Anthony D Marinov; Raphael Hirsch
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

8.  Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo.

Authors:  R G Jones; M Parsons; M Bonnard; V S Chan; W C Yeh; J R Woodgett; P S Ohashi
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

9.  Two waves of nuclear factor kappaB recruitment to target promoters.

Authors:  S Saccani; S Pantano; G Natoli
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

Review 10.  Post-transcriptional regulation of pro-inflammatory gene expression.

Authors:  A Clark
Journal:  Arthritis Res       Date:  2000-03-31
View more
  30 in total

Review 1.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

2.  Low-level arsenic causes chronic inflammation and suppresses expression of phagocytic receptors.

Authors:  Priyanka Prasad; Dona Sinha
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-22       Impact factor: 4.223

3.  Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis.

Authors:  A Verwoerd; D Hijdra; A D M Vorselaars; H A Crommelin; C H M van Moorsel; J C Grutters; A M E Claessen
Journal:  Clin Exp Immunol       Date:  2016-07-12       Impact factor: 4.330

4.  Akt-1 and Akt-2 Differentially Regulate the Development of Experimental Autoimmune Encephalomyelitis by Controlling Proliferation of Thymus-Derived Regulatory T Cells.

Authors:  Song Ouyang; Qiuming Zeng; Na Tang; Hui Guo; Rong Tang; Weifan Yin; Aimin Wang; Hongyu Tang; Jiru Zhou; Hong Xie; Wallace Y Langdon; Huan Yang; Jian Zhang
Journal:  J Immunol       Date:  2019-01-28       Impact factor: 5.422

5.  T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells.

Authors:  Guilin Qiao; Yixia Zhao; Zhenping Li; Peter Q Tang; Wallace Y Langdon; Tianlan Yang; Jian Zhang
Journal:  J Immunol       Date:  2013-06-07       Impact factor: 5.422

Review 6.  The emerging role of Wnt5a in the promotion of a pro-inflammatory and immunosuppressive tumor microenvironment.

Authors:  Pablo Lopez-Bergami; Gastón Barbero
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

7.  Phosphorylation of Carma1, but not Bcl10, by Akt regulates TCR/CD28-mediated NF-κB induction and cytokine production.

Authors:  Jing Cheng; Kristia S Hamilton; Lawrence P Kane
Journal:  Mol Immunol       Date:  2014-02-16       Impact factor: 4.407

Review 8.  TCR signaling to NF-κB and mTORC1: Expanding roles of the CARMA1 complex.

Authors:  Jian-hong Shi; Shao-Cong Sun
Journal:  Mol Immunol       Date:  2015-08-08       Impact factor: 4.407

9.  T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10.

Authors:  Kristia S Hamilton; Binh Phong; Catherine Corey; Jing Cheng; Balachandra Gorentla; Xiaoping Zhong; Sruti Shiva; Lawrence P Kane
Journal:  Sci Signal       Date:  2014-06-10       Impact factor: 8.192

Review 10.  The role of CARMA1 in T cells.

Authors:  Marly I Roche; Ravisankar A Ramadas; Benjamin D Medoff
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.